| regulation of cytokine production | GO:0001817 | 266 | 0.408 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.218 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.174 | |
| interspecies interaction between organisms | GO:0044419 | 83 | 0.168 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.166 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.153 | |
| regulation of response to biotic stimulus | GO:0002831 | 38 | 0.152 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.148 | |
| type i interferon production | GO:0032606 | 29 | 0.148 | |
| cytokine production | GO:0001816 | 319 | 0.145 | |
| regulation of defense response | GO:0031347 | 233 | 0.140 | |
| regulation of innate immune response | GO:0045088 | 91 | 0.138 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.132 | |
| innate immune response | GO:0045087 | 157 | 0.127 | |
| positive regulation of interferon alpha production | GO:0032727 | 4 | 0.118 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 83 | 0.118 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.106 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.100 | |
| regulation of type i interferon production | GO:0032479 | 22 | 0.099 | |
| immune effector process | GO:0002252 | 321 | 0.092 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.092 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.089 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.087 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.087 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.086 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.084 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.082 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.079 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.078 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.074 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.069 | |
| intracellular protein transport | GO:0006886 | 204 | 0.068 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.067 | |
| cellular response to lipopolysaccharide | GO:0071222 | 77 | 0.064 | |
| cellular response to lipid | GO:0071396 | 145 | 0.064 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.063 | |
| defense response to other organism | GO:0098542 | 197 | 0.063 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.062 | |
| cellular response to interferon beta | GO:0035458 | 21 | 0.062 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.060 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.059 | |
| regulation of intracellular protein transport | GO:0033157 | 82 | 0.059 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.058 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.058 | |
| activation of immune response | GO:0002253 | 138 | 0.057 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.056 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.056 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.055 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.055 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.055 | |
| rig i signaling pathway | GO:0039529 | 4 | 0.053 | |
| dna metabolic process | GO:0006259 | 303 | 0.053 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.053 | |
| defense response to bacterium | GO:0042742 | 119 | 0.052 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.051 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.050 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.050 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.049 | |
| protein import into nucleus | GO:0006606 | 95 | 0.049 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.048 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.047 | |
| defense response to virus | GO:0051607 | 68 | 0.047 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.047 | |
| regulation of protein localization | GO:0032880 | 231 | 0.046 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.046 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.046 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.045 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.044 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.043 | |
| protein import | GO:0017038 | 101 | 0.043 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.043 | |
| interleukin 8 production | GO:0032637 | 4 | 0.042 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.042 | |
| cytoplasmic pattern recognition receptor signaling pathway in response to virus | GO:0039528 | 4 | 0.042 | |
| regulation of antimicrobial peptide biosynthetic process | GO:0002805 | 1 | 0.042 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.042 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.042 | |
| protein localization to organelle | GO:0033365 | 185 | 0.041 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.041 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.041 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.040 | |
| b cell activation | GO:0042113 | 161 | 0.039 | |
| leukocyte mediated cytotoxicity | GO:0001909 | 62 | 0.039 | |
| positive regulation of innate immune response | GO:0045089 | 80 | 0.038 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.038 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.038 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.038 | |
| inflammatory response | GO:0006954 | 244 | 0.038 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.037 | |
| positive regulation of type i interferon production | GO:0032481 | 14 | 0.037 | |
| activation of innate immune response | GO:0002218 | 56 | 0.037 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.036 | |
| response to dsrna | GO:0043331 | 30 | 0.035 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 85 | 0.035 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.035 | Mouse |
| protein maturation | GO:0051604 | 176 | 0.035 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.034 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.034 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.034 | |
| response to interferon gamma | GO:0034341 | 34 | 0.034 | |
| immune response regulating signaling pathway | GO:0002764 | 125 | 0.034 | |
| atp metabolic process | GO:0046034 | 75 | 0.033 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.033 | |
| defense response to gram positive bacterium | GO:0050830 | 50 | 0.033 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.033 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.033 | |
| membrane organization | GO:0061024 | 245 | 0.032 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.032 | |
| positive regulation of immune effector process | GO:0002699 | 107 | 0.032 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.032 | |
| regulation of defense response to bacterium | GO:1900424 | 3 | 0.032 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 80 | 0.032 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.032 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.031 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.031 | |
| negative regulation of cytokine production | GO:0001818 | 84 | 0.031 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.031 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.031 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.030 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.030 | |
| immune response activating signal transduction | GO:0002757 | 116 | 0.030 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.030 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.030 | |
| regulation of nucleocytoplasmic transport | GO:0046822 | 73 | 0.029 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.029 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.029 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.029 | |
| regulation of protein targeting | GO:1903533 | 61 | 0.028 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.028 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.028 | |
| stem cell development | GO:0048864 | 219 | 0.028 | |
| respiratory system development | GO:0060541 | 190 | 0.028 | |
| transmembrane transport | GO:0055085 | 412 | 0.028 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.028 | |
| hatching | GO:0035188 | 4 | 0.028 | |
| regulation of schwann cell proliferation | GO:0010624 | 2 | 0.027 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.026 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.026 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.026 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.026 | |
| negative regulation of multi organism process | GO:0043901 | 68 | 0.026 | |
| protein processing | GO:0016485 | 163 | 0.025 | |
| single organism nuclear import | GO:1902593 | 95 | 0.025 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.025 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.025 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.025 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.025 | |
| regulation of leukocyte apoptotic process | GO:2000106 | 56 | 0.025 | |
| compound eye development | GO:0048749 | 1 | 0.024 | |
| gtp catabolic process | GO:0006184 | 143 | 0.024 | |
| nuclear transport | GO:0051169 | 139 | 0.024 | |
| regulation of interferon alpha production | GO:0032647 | 5 | 0.024 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 81 | 0.024 | |
| negative regulation of intracellular transport | GO:0032387 | 38 | 0.024 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.024 | |
| positive regulation of antimicrobial humoral response | GO:0002760 | 2 | 0.024 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.023 | |
| oxidation reduction process | GO:0055114 | 342 | 0.023 | |
| mitochondrion organization | GO:0007005 | 134 | 0.023 | |
| viral life cycle | GO:0019058 | 36 | 0.023 | |
| regulation of autophagy | GO:0010506 | 30 | 0.023 | |
| membrane depolarization | GO:0051899 | 64 | 0.023 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.023 | |
| regulation of antimicrobial humoral response | GO:0002759 | 3 | 0.023 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.023 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.022 | |
| protein ubiquitination | GO:0016567 | 171 | 0.022 | |
| cation transport | GO:0006812 | 399 | 0.022 | |
| regulation of nlrp3 inflammasome complex assembly | GO:1900225 | 4 | 0.022 | |
| epidermis development | GO:0008544 | 187 | 0.022 | |
| maintenance of location | GO:0051235 | 89 | 0.022 | |
| defense response to gram negative bacterium | GO:0050829 | 28 | 0.022 | |
| positive regulation of rig i signaling pathway | GO:1900246 | 1 | 0.022 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.022 | |
| antimicrobial peptide biosynthetic process | GO:0002777 | 2 | 0.022 | |
| lung development | GO:0030324 | 164 | 0.022 | |
| regulation of interleukin 1 alpha production | GO:0032650 | 4 | 0.021 | |
| pattern recognition receptor signaling pathway | GO:0002221 | 47 | 0.021 | |
| regulation of rig i signaling pathway | GO:0039535 | 2 | 0.021 | |
| negative regulation of intracellular protein transport | GO:0090317 | 27 | 0.021 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.021 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.021 | |
| protein targeting | GO:0006605 | 143 | 0.021 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.021 | |
| regulation of protein transport | GO:0051223 | 163 | 0.021 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.020 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.020 | |
| negative regulation of interferon alpha production | GO:0032687 | 1 | 0.020 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.020 | |
| regulation of secretion | GO:0051046 | 274 | 0.020 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.020 | |
| macromolecule glycosylation | GO:0043413 | 55 | 0.020 | |
| regulation of protein localization to nucleus | GO:1900180 | 60 | 0.019 | |
| respiratory tube development | GO:0030323 | 167 | 0.019 | |
| progesterone metabolic process | GO:0042448 | 4 | 0.019 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.019 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.019 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.019 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.019 | |
| natural killer cell proliferation | GO:0001787 | 3 | 0.019 | |
| negative regulation of nlrp3 inflammasome complex assembly | GO:1900226 | 2 | 0.019 | |
| negative regulation of protein transport | GO:0051224 | 46 | 0.018 | |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 57 | 0.018 | |
| protein catabolic process | GO:0030163 | 221 | 0.018 | Mouse |
| cell killing | GO:0001906 | 67 | 0.018 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.018 | |
| response to endoplasmic reticulum stress | GO:0034976 | 53 | 0.018 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.018 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.018 | |
| pyroptosis | GO:0070269 | 8 | 0.018 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.018 | |
| innate immune response activating signal transduction | GO:0002758 | 50 | 0.018 | |
| endomembrane system organization | GO:0010256 | 147 | 0.018 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.018 | |
| regulation of interleukin 8 production | GO:0032677 | 3 | 0.018 | |
| nucleic acid phosphodiester bond hydrolysis | GO:0090305 | 49 | 0.018 | |
| antibacterial peptide production | GO:0002778 | 2 | 0.017 | |
| rna processing | GO:0006396 | 105 | 0.017 | |
| nuclear import | GO:0051170 | 95 | 0.017 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.017 | |
| adaptive immune response | GO:0002250 | 155 | 0.017 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 80 | 0.017 | |
| regulation of protein import into nucleus | GO:0042306 | 52 | 0.017 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.017 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.017 | |
| peptide metabolic process | GO:0006518 | 46 | 0.017 | |
| positive regulation of antimicrobial peptide biosynthetic process | GO:0002807 | 1 | 0.017 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.017 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.017 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.016 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.016 | |
| regulation of protein ubiquitination | GO:0031396 | 52 | 0.016 | |
| stem cell differentiation | GO:0048863 | 268 | 0.016 | |
| regulation of protein modification by small protein conjugation or removal | GO:1903320 | 57 | 0.016 | |
| viral process | GO:0016032 | 41 | 0.016 | |
| spleen development | GO:0048536 | 39 | 0.016 | |
| cellular amide metabolic process | GO:0043603 | 58 | 0.016 | |
| positive regulation of endopeptidase activity | GO:0010950 | 43 | 0.016 | |
| positive regulation of viral entry into host cell | GO:0046598 | 3 | 0.016 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.016 | |
| regulation of cell activation | GO:0050865 | 289 | 0.016 | |
| dna repair | GO:0006281 | 107 | 0.016 | |
| amine metabolic process | GO:0009308 | 45 | 0.016 | |
| muscle cell development | GO:0055001 | 133 | 0.016 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.016 | |
| connective tissue development | GO:0061448 | 179 | 0.016 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.016 | |
| cell adhesion | GO:0007155 | 329 | 0.016 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.016 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.016 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.016 | |
| digestive system development | GO:0055123 | 200 | 0.016 | |
| interferon beta production | GO:0032608 | 16 | 0.016 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.016 | |
| multicellular organism growth | GO:0035264 | 161 | 0.016 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.016 | |
| leukocyte apoptotic process | GO:0071887 | 71 | 0.015 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.015 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.015 | |
| i kappab kinase nf kappab signaling | GO:0007249 | 85 | 0.015 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.015 | |
| positive regulation of type i interferon mediated signaling pathway | GO:0060340 | 4 | 0.015 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.015 | |
| action potential | GO:0001508 | 78 | 0.015 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.015 | |
| er nucleus signaling pathway | GO:0006984 | 27 | 0.015 | |
| anion transport | GO:0006820 | 177 | 0.015 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.015 | |
| regulation of defense response to virus by host | GO:0050691 | 8 | 0.015 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.015 | |
| positive regulation of viral genome replication | GO:0045070 | 2 | 0.015 | |
| lymphocyte apoptotic process | GO:0070227 | 54 | 0.015 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.015 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.014 | |
| muscle tissue development | GO:0060537 | 308 | 0.014 | |
| sensory perception | GO:0007600 | 245 | 0.014 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.014 | |
| glycosylation | GO:0070085 | 62 | 0.014 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.014 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.014 | |
| rna interference | GO:0016246 | 2 | 0.014 | |
| viral gene expression | GO:0019080 | 3 | 0.014 | |
| angiogenesis | GO:0001525 | 201 | 0.014 | |
| adhesion of symbiont to host | GO:0044406 | 8 | 0.014 | |
| cation homeostasis | GO:0055080 | 212 | 0.014 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.014 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.014 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.014 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.014 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.014 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.014 | |
| positive regulation of mda 5 signaling pathway | GO:1900245 | 1 | 0.014 | |
| ossification | GO:0001503 | 216 | 0.014 | |
| neuronal action potential | GO:0019228 | 54 | 0.014 | |
| purine ribonucleoside monophosphate catabolic process | GO:0009169 | 57 | 0.013 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.013 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.013 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.013 | |
| regulation of b cell activation | GO:0050864 | 81 | 0.013 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.013 | |
| chromatin organization | GO:0006325 | 206 | 0.013 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.013 | |
| positive regulation of peptidase activity | GO:0010952 | 49 | 0.013 | |
| positive regulation of cysteine type endopeptidase activity | GO:2001056 | 39 | 0.013 | |
| autophagy | GO:0006914 | 45 | 0.013 | |
| amide transport | GO:0042886 | 138 | 0.013 | |
| leukocyte homeostasis | GO:0001776 | 79 | 0.013 | |
| skeletal system development | GO:0001501 | 356 | 0.013 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.013 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.013 | |
| negative regulation of cytoplasmic transport | GO:1903650 | 29 | 0.013 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.013 | |
| hormone metabolic process | GO:0042445 | 86 | 0.013 | |
| epithelial cell development | GO:0002064 | 159 | 0.013 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.013 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.012 | |
| urogenital system development | GO:0001655 | 261 | 0.012 | Mouse |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.012 | |
| interleukin 6 production | GO:0032635 | 58 | 0.012 | |
| antimicrobial peptide production | GO:0002775 | 2 | 0.012 | |
| regulation of interferon gamma production | GO:0032649 | 57 | 0.012 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.012 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.012 | |
| regulation of neuron death | GO:1901214 | 134 | 0.012 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.012 | |
| limb morphogenesis | GO:0035108 | 149 | 0.012 | |
| ear development | GO:0043583 | 200 | 0.012 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.012 | |
| synaptic transmission | GO:0007268 | 329 | 0.012 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.012 | |
| meiotic cell cycle process | GO:1903046 | 77 | 0.012 | |
| regulation of viral genome replication | GO:0045069 | 13 | 0.012 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.012 | |
| double strand break repair | GO:0006302 | 48 | 0.012 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.012 | |
| negative regulation of protein localization to nucleus | GO:1900181 | 23 | 0.012 | |
| regulation of actin nucleation | GO:0051125 | 4 | 0.012 | |
| rhythmic process | GO:0048511 | 174 | 0.011 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.011 | |
| t cell activation | GO:0042110 | 289 | 0.011 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.011 | |
| extracellular structure organization | GO:0043062 | 148 | 0.011 | |
| t cell mediated cytotoxicity | GO:0001913 | 26 | 0.011 | |
| atp catabolic process | GO:0006200 | 55 | 0.011 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.011 | |
| defense response to protozoan | GO:0042832 | 25 | 0.011 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.011 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 62 | 0.011 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.011 | |
| purine nucleoside monophosphate catabolic process | GO:0009128 | 58 | 0.011 | |
| regulation of natural killer cell mediated cytotoxicity | GO:0042269 | 19 | 0.011 | |
| mapk cascade | GO:0000165 | 281 | 0.011 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.011 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.011 | |
| b cell activation involved in immune response | GO:0002312 | 50 | 0.011 | |
| stem cell maintenance | GO:0019827 | 130 | 0.011 | |
| regulation of antimicrobial peptide production | GO:0002784 | 1 | 0.011 | |
| mrna metabolic process | GO:0016071 | 84 | 0.011 | |
| regulation of lymphocyte differentiation | GO:0045619 | 107 | 0.011 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.011 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.011 | |
| activation of cysteine type endopeptidase activity | GO:0097202 | 27 | 0.011 | |
| organism emergence from protective structure | GO:0071684 | 4 | 0.011 | |
| organic anion transport | GO:0015711 | 137 | 0.011 | |
| lymphocyte activation involved in immune response | GO:0002285 | 93 | 0.011 | |
| positive regulation of interleukin 1 alpha secretion | GO:0050717 | 3 | 0.011 | |
| response to nutrient levels | GO:0031667 | 109 | 0.011 | |
| gtp metabolic process | GO:0046039 | 144 | 0.011 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.011 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.011 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.011 | |
| regulation of lymphocyte apoptotic process | GO:0070228 | 41 | 0.011 | |
| lipid localization | GO:0010876 | 126 | 0.011 | |
| natural killer cell activation | GO:0030101 | 44 | 0.011 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.011 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.011 | |
| regulation of production of molecular mediator of immune response | GO:0002700 | 65 | 0.011 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.011 | |
| immunoglobulin production | GO:0002377 | 73 | 0.011 | |
| microtubule based process | GO:0007017 | 236 | 0.011 | |
| response to oxidative stress | GO:0006979 | 123 | 0.011 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.011 | |
| limb development | GO:0060173 | 166 | 0.010 | |
| response to peptide hormone | GO:0043434 | 127 | 0.010 | |
| schwann cell proliferation | GO:0014010 | 2 | 0.010 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.010 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.010 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.010 | |
| positive regulation of reactive oxygen species metabolic process | GO:2000379 | 11 | 0.010 | |
| cartilage development | GO:0051216 | 140 | 0.010 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.010 | |
| striated muscle cell development | GO:0055002 | 125 | 0.010 | |
| response to light stimulus | GO:0009416 | 135 | 0.010 | |
| negative regulation of protein modification by small protein conjugation or removal | GO:1903321 | 20 | 0.010 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.010 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.010 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.010 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.010 | |
| skin development | GO:0043588 | 220 | 0.010 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 88 | 0.010 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 2 | 0.010 | |
| t cell apoptotic process | GO:0070231 | 39 | 0.010 | |
| negative regulation of immune effector process | GO:0002698 | 55 | 0.010 | |
| response to radiation | GO:0009314 | 165 | 0.010 | |
| protein glycosylation | GO:0006486 | 55 | 0.010 | |
| response to growth factor | GO:0070848 | 198 | 0.010 | |
| glial cell differentiation | GO:0010001 | 131 | 0.010 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.010 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.010 | |
| cell fate commitment | GO:0045165 | 210 | 0.010 | |
| nucleoside monophosphate catabolic process | GO:0009125 | 59 | 0.010 | |
